Very disappointing to all LTH. The company misses every milestone and fails to update shareholders on where things are. I think we should all require the company to provide a detailed update on all missing regulatory approvals (including known reasons for any delays), MOUs status and other revenue channels. Yacov should consider resigning and appointing a new CEO given the latest results (or lack of results) and share price performance
- Forums
- ASX - By Stock
- GMV
- Ann: Quarterly Activities and Cashflow Report
Ann: Quarterly Activities and Cashflow Report, page-160
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online